Thai PBS Thai PBS
฿211 million approved for study of Thailand's first plant-based COVID vaccine

฿211 million approved for study of Thailand's first plant-based COVID vaccine

13 Sept 08:16 Key points summarised by AI
  • Thailand's cabinet approved a ฿211 million budget to study the safety and efficacy of the country's first plant-based COVID-19 vaccine, developed by Thai startup Baiya Phytopharm.
  • The National Vaccine Institute and Baiya Phytopharm are expediting Phase Three of the vaccine program, with Phase One human trials already completed safely.
Read full article
News 1/1
Skip > Skip >